BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 21635190)

  • 1. Drugs with anticholinergic properties: a current perspective on use and safety.
    Gerretsen P; Pollock BG
    Expert Opin Drug Saf; 2011 Sep; 10(5):751-65. PubMed ID: 21635190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment?
    Desmarais JE; Beauclair L; Margolese HC
    J Psychopharmacol; 2012 Sep; 26(9):1167-74. PubMed ID: 22651987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergics: theoretical and clinical overview.
    Nishtala PS; Salahudeen MS; Hilmer SN
    Expert Opin Drug Saf; 2016 Jun; 15(6):753-68. PubMed ID: 26966981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact on cognitive function of anticholinergic drugs used for the treatment of overactive bladder in the elderly].
    Kerdraon J; Robain G; Jeandel C; Mongiat Artus P; Gamé X; Fatton B; Scheiber-Nogueira MC; Vetel JM; Mares P; Petit AC; Amarenco G;
    Prog Urol; 2014 Sep; 24(11):672-81. PubMed ID: 25214448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.
    Ness J; Hoth A; Barnett MJ; Shorr RI; Kaboli PJ
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):42-51. PubMed ID: 16730620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The adverse effects of anticholinergic drugs].
    Iwaki H; Nomoto M
    Brain Nerve; 2014 May; 66(5):551-60. PubMed ID: 24807371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticholinergic scales: Use in psychiatry and update of the anticholinergic impregnation scale].
    Javelot H; Meyer G; Becker G; Post G; Runge V; Pospieszynski P; Schneiderlin T; Armand-Branger S; Michel B; Weiner L; Faria CGF; Drapier D; Fakra E; Fossati P; Haffen E; Yrondi A; Hingray C
    Encephale; 2022 Jun; 48(3):313-324. PubMed ID: 34876278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anticholinergic activity levels and delirium in the elderly.
    Tune LE
    Semin Clin Neuropsychiatry; 2000 Apr; 5(2):149-53. PubMed ID: 10837103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study.
    Pasina L; Colzani L; Cortesi L; Tettamanti M; Zambon A; Nobili A; Mazzone A; Mazzola P; Annoni G; Bellelli G
    Drugs Aging; 2019 Jan; 36(1):85-91. PubMed ID: 30484239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive function.
    Ogino S; Miyamoto S; Miyake N; Yamaguchi N
    Psychiatry Clin Neurosci; 2014 Jan; 68(1):37-49. PubMed ID: 24102938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia.
    Bhattacharya R; Chatterjee S; Carnahan RM; Aparasu RR
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):434-41. PubMed ID: 22030114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly.
    Kay GG; Granville LJ
    Clin Ther; 2005 Jan; 27(1):127-38; quiz 139-40. PubMed ID: 15763613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic drug burden in older people's brain - how well is it measured?
    Kersten H; Wyller TB
    Basic Clin Pharmacol Toxicol; 2014 Feb; 114(2):151-9. PubMed ID: 24112192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cognitive impact of anticholinergics: a clinical review.
    Campbell N; Boustani M; Limbil T; Ott C; Fox C; Maidment I; Schubert CC; Munger S; Fick D; Miller D; Gulati R
    Clin Interv Aging; 2009; 4():225-33. PubMed ID: 19554093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinergic activity of commonly prescribed medications and neuropsychiatric adverse events in older people.
    Nishtala PS; Fois RA; McLachlan AJ; Bell JS; Kelly PJ; Chen TF
    J Clin Pharmacol; 2009 Oct; 49(10):1176-84. PubMed ID: 19783711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation.
    Koshoedo S; Soiza RL; Purkayastha R; Mangoni AA
    Am J Geriatr Pharmacother; 2012 Aug; 10(4):251-7. PubMed ID: 22795433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
    Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic and sedative medicines - prescribing considerations for people with dementia.
    Bell JS; Mezrani C; Blacker N; LeBlanc T; Frank O; Alderman CP; Rossi S; Rowett D; Shute R
    Aust Fam Physician; 2012; 41(1-2):45-9. PubMed ID: 22276284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
    Green AR; Reifler LM; Boyd CM; Weffald LA; Bayliss EA
    Drugs Aging; 2018 Mar; 35(3):223-232. PubMed ID: 29404965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of medications with anticholinergic properties and cognitive function in a young-old community sample.
    Low LF; Anstey KJ; Sachdev P
    Int J Geriatr Psychiatry; 2009 Jun; 24(6):578-84. PubMed ID: 19021151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.